NAS:DNLI (USA) Also trade in: Germany
Denali Therapeutics Inc
$ 19.63 0 (0%)
|Volume:||370,430||Avg Vol (1m):||381,177|
|Market Cap $:||1.87 Bil||Enterprise Value $:||1.39 Bil|
|Earnings Power Value||0|
|Net Current Asset Value||3.58|
|Median P/S Value||656.48|
|Peter Lynch Value||0|
|DCF (FCF Based)||0|
|DCF (Earnings Based)||0|
Float Percentage of TSO
Short Interest History (%)
Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.
Insider ownership (%)
This is the historical insider ownership of Denali Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.